share_log

Will Weakness in WuXi AppTec Co., Ltd.'s (SHSE:603259) Stock Prove Temporary Given Strong Fundamentals?

Will Weakness in WuXi AppTec Co., Ltd.'s (SHSE:603259) Stock Prove Temporary Given Strong Fundamentals?

鉴于强大的基本面,药明康德(SHSE:603259)股票的疲软是否只是暂时的?
Simply Wall St ·  09/05 18:28

WuXi AppTec (SHSE:603259) has had a rough month with its share price down 8.6%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in value in the long-term, given how markets usually reward companies with good financial health. In this article, we decided to focus on WuXi AppTec's ROE.

药明康德(SHSE:603259)的股价在一个月内下跌了8.6%。但如果你仔细观察,你可能会发现它的强劲财务状况意味着股票在长期内有可能看涨,因为市场通常会奖励财务状况良好的公司。在本文中,我们决定重点关注药明康德的roe。

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. Simply put, it is used to assess the profitability of a company in relation to its equity capital.

股东权益回报率(ROE)是测试公司如何有效地增加其价值并管理投资者资金的指标。简而言之,它用于评估公司相对于股本资本的盈利能力。

How To Calculate Return On Equity?

如何计算股东权益报酬率?

ROE can be calculated by using the formula:

净资产收益率可以使用以下公式进行计算:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

净资产收益率 = 净利润(从持续经营中获得)÷ 股东权益

So, based on the above formula, the ROE for WuXi AppTec is:

因此,根据以上公式,药明康德的roe是:

16% = CN¥8.6b ÷ CN¥55b (Based on the trailing twelve months to June 2024).

16% = CN¥86亿 ÷ CN¥550亿(基于截至2024年6月的过去12个月)。

The 'return' is the profit over the last twelve months. So, this means that for every CN¥1 of its shareholder's investments, the company generates a profit of CN¥0.16.

“回报”是过去12个月的利润。这意味着,对于其股东的每1元人民币投资,公司可以创造CN¥0.16的利润。

Why Is ROE Important For Earnings Growth?

ROE为什么对净利润增长很重要?

We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.

我们已经确定,ROE是一个公司未来盈利的高效测量工具。基于公司选择重新投资或“保留”多少利润,我们可以评估公司未来产生利润的能力。假设其他条件相同,具有更高股本回报率和更高利润保留比的公司通常增长速度较高,而没有相同特征的公司则通常增长速度较低。

WuXi AppTec's Earnings Growth And 16% ROE

药明康德的盈利增长和16%的roe

At first glance, WuXi AppTec seems to have a decent ROE. Especially when compared to the industry average of 6.7% the company's ROE looks pretty impressive. This probably laid the ground for WuXi AppTec's significant 34% net income growth seen over the past five years. We reckon that there could also be other factors at play here. For example, it is possible that the company's management has made some good strategic decisions, or that the company has a low payout ratio.

乍一看,药明康德的roe似乎不错。特别是与行业平均6.7%的roe相比,该公司的roe看起来相当令人印象深刻。这可能为药明康德过去五年中显著的34%净利润增长奠定了基础。我们认为这里可能还有其他因素起作用。例如,公司的管理层可能做出了一些良好的战略决策,或者公司的派息比例比较低。

Next, on comparing with the industry net income growth, we found that WuXi AppTec's growth is quite high when compared to the industry average growth of 20% in the same period, which is great to see.

接下来,我们将药明康德的净利润增长与行业平均增长20%进行比较,发现药明康德的增长相当高,这是非常好的。

big
SHSE:603259 Past Earnings Growth September 5th 2024
SHSE:603259过去的盈利增长截至2024年9月5日

Earnings growth is a huge factor in stock valuation. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if WuXi AppTec is trading on a high P/E or a low P/E, relative to its industry.

盈利增长是股票估值的重要因素。投资者应该尝试确定预期的盈利增长或下降是否已反映在股价中。这有助于他们判断股票的未来走势是光明还是黯淡。预期盈利增长的一个好指标是市盈率,它根据盈利前景确定市场愿意支付的股票价格。所以,您可能会想查看药明康德的市盈率相对于其所在行业是高还是低。

Is WuXi AppTec Making Efficient Use Of Its Profits?

药明康德是否有效利用其利润?

WuXi AppTec's three-year median payout ratio is a pretty moderate 28%, meaning the company retains 72% of its income. By the looks of it, the dividend is well covered and WuXi AppTec is reinvesting its profits efficiently as evidenced by its exceptional growth which we discussed above.

药明康德的三年中位数派息比率相当适中,为28%,意味着该公司保留了72%的收入。从表面上看,分红是很充裕的,药明康德以其出色的增长表现再投资其利润,如前所述。

Additionally, WuXi AppTec has paid dividends over a period of five years which means that the company is pretty serious about sharing its profits with shareholders. Based on the latest analysts' estimates, we found that the company's future payout ratio over the next three years is expected to hold steady at 28%. Therefore, the company's future ROE is also not expected to change by much with analysts predicting an ROE of 15%.

此外,药明康德在过去五年中支付了股息,这意味着该公司非常愿意与股东分享利润。根据最新的分析师预测,我们发现该公司未来三年的派息比率预计将持稳在28%。因此,按照分析师预测,该公司未来的ROE也不会有太大变化,预计为15%。

Summary

总的来说,我们对伟明环保的表现非常满意。具体而言,我们喜欢公司以高回报率再投资了其利润的很大一部分。当然,这导致公司的收益大幅增长。但是,最新的行业分析师预测表明,该公司的收益预计将加速增长。

Overall, we are quite pleased with WuXi AppTec's performance. In particular, it's great to see that the company is investing heavily into its business and along with a high rate of return, that has resulted in a sizeable growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings growth is expected to slow down. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.

总体而言,我们对药明康德的表现感到非常满意。特别是,公司正在大量投资业务,并且以较高的回报率带来了可观的收益增长。然而,根据最新的行业分析师预测,公司的盈利增长有望放缓。要了解更多关于公司未来盈利增长预测的信息,请查看这份关于分析师预测的免费报告。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发